Market Research Logo

Venezuela Pharmaceuticals and Healthcare Report Q2 2016

Venezuela Pharmaceuticals and Healthcare Report Q2 2016

BMI View: Pharmaceutical companies exposed to Venezuela's debt issues will have few options but to accept the bonds or any other technical/non-cash repayment terms developed by the government in the future. The costs of such deals have been long expected and will be unlikely to be more damaging. Foreign currency controls, drug price controls, currency devaluation and delayed debt payments will continue to plague drugmakers until the country abolishes structurally distorting policies.

Headline Expenditure Projections

Pharmaceuticals: VEB88.7bn (USD3.0bn) in 2015 to VEB259.6bn (USD1.3bn) in 2016; +192.6% in local currency terms and -57.2% in US dollar terms. Forecast has been revised upward from Q116 in local currency terms due to updated macroeconomic considerations.

Healthcare: VEB246.5bn (USD8.4bn) in 2015 to VEB815.8bn (USD12.5bn) in 2016; +231% in local currency terms and +47.9% in US dollar terms. Forecast has been revised upward from Q116 due to updated macroeconomic considerations.


BMI Industry View
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Venezuela 2012-2020)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Venezuela 2012-2020)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Venezuela 2012-2020)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Venezuela 2012-2020)
Prescription Drug
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Venezuela 2012-2020)
Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Venezuela 2012-2020)
Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Venezuela 2012-2020)
OTC Medicine Market Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Venezuela 2012-2020)
Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Venezuela 2014-2020)
Table: Pharmaceutical Trade Data And Forecasts local currency (Venezuela 2014-2020)
Industry Risk/Reward Index
Americas Risk/Reward Index
Venezuela Risk/Reward Index
Rewards
Risks
Regulatory Review
Intellectual Property Issues
Pricing Regime
Reimbursement Regime
Market Overview
Healthcare Sector
Table: Healthcare Resources (Venezuela 2010-2015)
Table: Healthcare Personnel (Venezuela 2010-2015)
Table: Healthcare Activity (Venezuela 2010-2015)
Research & Development
Clinical Trials
Epidemiology
Competitive Landscape
Research-Based Industry
Generic Drugmakers
Pharmaceutical Distribution
Pharmaceutical Retail Sector
Company Profile
Boehringer Ingelheim
Calox International
Elmor
GlaxoSmithKline
Grupo Farma
Merck & Co
Novartis
Pfizer
Sanofi
Strides Latina (Sumifarma)
Demographic Forecast
Demographic Outlook 2015
Table: Population Headline Indicators (Venezuela 1990-2025)
Table: Key Population Ratios (Venezuela 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Venezuela 1990-2025)
Table: Population By Age Group (Venezuela 1990-2025)
Table: Population By Age Group % (Venezuela 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators
Indicator Weightings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report